RMD
$251.21
Resmed
($3.79)
(1.49%)
RMD
Earnings Whisper ®
N/A
2nd Quarter December 2021
Consensus:  $1.48
Revenue:  $922.63 Mil
Thursday
Jan 27
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RMD reports earnings?
Beat
Meet
Miss

Where is RMD's stock price going from here?
Up
Flat
Down
Stock chart of RMD
Analysts
Summary of analysts' recommendations for RMD
Score
Grade
Pivots
Resistance
$265.50
$262.34
$256.77

$253.61

Support
$248.04
$244.88
$239.31
Tweet
Growth
Description
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Peers
Boston ScientificAbbottStryker3MBecton, DickinsonWatersBaxter InternationalCardiovascular SystemsTeleflexIntegra LifeSciences Holdings